Vivimed Labs Ltd. (VIVIMEDLAB)
MSE MSE Primary XNSE Summary
VIVIMEDLAB Chart
Vivimed Labs Ltd. (VIVIMEDLAB) FAQ
What does "Delisted" mean?
What was the last recorded dividend?
How long did the company pay dividends?
Were there any stock splits?
What was the last known trading price?
Vivimed Labs Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | MSE Exchange | INE526G01021 ISIN |
| India Country | 607 Employees | - Last Dividend | 6 Apr 2016 Last Split | - IPO Date |
Overview
Vivimed Labs Limited, established in 1988 and headquartered in Hyderabad, India, is a prominent player in the pharmaceutical and specialty chemicals market. The company, along with its subsidiaries, is engaged in the manufacturing and selling of active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations primarily in India. Vivimed Labs operates across two major segments: Speciality Chemicals Business and Pharma Business. It caters to a wide range of therapeutic segments and industries, including home, personal, and industrial care. In addition to serving the domestic market, Vivimed Labs also exports its products, showcasing its global outreach.
Products and Services
Vivimed Labs offers a diverse portfolio of products and services across various sectors:
- Active Pharmaceutical Ingredients (APIs) and Intermediates: The company supplies APIs and intermediates to generic and ethical pharmaceutical companies worldwide, making a significant contribution to global healthcare.
- Finished Dosage Formulations: Vivimed Labs develops and produces a wide range of finished dosage forms, including capsules, tablets, syrups, liquids, nasal sprays, and ointments targeting therapeutic areas such as ophthalmic, nutraceuticals, dermatology, and pain management.
- Contract Manufacturing: Offering contract manufacturing services, Vivimed Labs provides customized solutions for capsules and tablets, syrups and liquids, and nasal sprays and ointments, addressing the needs of its partners in the pharmaceutical industry.
- Branded Formulations: The company markets branded formulations in various therapeutic segments, catering to the nuanced needs of patients and healthcare providers.
- Specialty Chemicals: Vivimed Labs produces specialty chemicals, including active ingredients primarily used in hair dye and photochromic applications, leveraging its chemical expertise in the industrial and personal care segments.
- Favulous Tablets: In response to the COVID-19 pandemic, Vivimed Labs introduced Favulous tablets, aimed at treating mild to moderate cases of COVID-19, showcasing the company's adaptability to global health challenges.
